Risk factors for recurrence after curative resection of hepatitis C-related hepatocellular carcinoma in patients without postoperative interferon therapy

Hepatology Research

Volumn 43, Issue 12, 2013, Pages 1313-1320

  Yamashita, Yo ichi ^a,b   Shirabe, Ken ^a   Toshima, Takeo ^a   Tsuijita, Eiji ^b   Takeishi, Kazuki ^b   Harimoto, Norifumi ^a   Ikegami, Toru ^a   Yoshizumi, Tomoharu ^a   Ikeda, Tetsuo ^a   Soejima, Yuji ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

Author keywords

Hepatitis C virus; Hepatocellular carcinoma; Risk factors; Tumor recurrence

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; DECARBOXYPROTHROMBIN; INTERFERON; PROTHROMBIN; TUMOR MARKER;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER SIZE; FOLLOW UP; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT; SURGICAL TECHNIQUE;

EID: 84890907258     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12091     Document Type: Article

References (28)

1. Lau WY. Management of hepatocellular carcinoma. J R Coll Surg Edinb 2002; 47: 389-399.
2. Tsai JF, Jeng JE, Ho MS etal. Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study. Br J Cancer 1997; 76: 968-974.
3. Sherlock S. Viruses and hepatocellular carcinoma. Gut 1994; 35: 828-832.
4. Liver Cancer Study Group of Japan. Primary liver cancer in Japan: primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 1990; 211: 277-287.
5. Adachi E, Maeda T, Matsumata T etal. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 1995; 108: 768-775.
6. Shirabe K, Takenaka K, Taketomi A etal. Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma. Cancer 1996; 77: 1050-1055.
7. Shirabe K, Wakiyama S, Gion T etal. Clinicopathological risk factors linked to recurrence pattern after curative hepatic resection for hepatocellular carcinoma - results of 152 resected cases. Hepatogastroenterology 2007; 54: 2084-2087.
8. Shirabe K, Shimada M, Kajiyama K etal. Clinicopathologic features of patients with hepatocellular carcinoma surviving >10 years after hepatic resection. Cancer 1998; 83: 2312-2316.
9. Tarao K, Takemiya S, Tamai S etal. Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC. Cancer 1997; 79: 688-694.
10. Tarao K, Rino Y, Takemiya S etal. Close association between high serum ALT and more rapid recurrence of hepatocellular carcinoma in hepatectomized patients with HCV-associated liver cirrhosis and hepatocellular carcinoma. Intervirology 2000; 43: 20-26.
11. Yeh CN, Chen MF, Lee WC, Jeng LB. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol 2002; 81: 195-202.
12. Kubo S, Hirohashi K, Tanaka H etal. Risk factors for recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. World J Surg 2000; 24: 1559-1565.
13. Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Shuto T, Kinoshita H. Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy. Br J Surg 2002; 89: 418-422.
14. Ikeda K, Arase Y, Saitoh S etal. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer. Hepatology 2000; 32: 228-232.
15. Shimada M, Takenaka K, Fujiwara Y etal. Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma. Br J Surg 1998; 85: 195-198.
16. Yamashita Y, Taketomi A, Itoh S etal. Long-term favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience. J Am Coll Surg 2007; 205: 19-26.
17. Makuuchi M, Mori T, Gunvén P, Yamazaki S, Hasegawa H. Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet 1987; 164: 155-158.
18. Lanois B. The intrahepatic Glissonian approach to liver resection. In: Blumgart LH, Fong Y, eds. Surgery of the Liver and Biliary Tract, 3rd edn. Vol. 2. London: WB Saunders, 2000; 1698-1703.
19. Takenaka K, Kawahara N, Yamamoto K etal. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg 1996; 131: 71-76.
20. Shimada M, Takenaka K, Taguchi K etal. Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 1998; 227: 80-85.
21. Kanematsu T, Furuta T, Takenaka K etal. A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 1989; 10: 98-102.
22. Shimada M, Takenaka K, Gion T etal. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 1996; 111: 720-726.
23. Portolani N, Coniglio A, Ghidoni S etal. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 2006; 243: 229-235.
24. Shirabe K, Takeishi K, Taketomi A, Uchiyama H, Kayashima H, Maehara Y. Improvement of long-term outcomes in hepatitis C virus antibody-positive patients with hepatocellular carcinoma after hepatectomy in the modern era. World J Surg 2011; 35: 1072-1084.
25. Taketomi A, Sanefuji K, Soejima Y etal. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation 2009; 87: 531-537.
26. Volpes R, Van Den Oord JJ, Desmet VJ. Vascular adhesion molecules in acute and chronic liver inflammation. Hepatology 1992; 15: 269-275.
27. Volpes R, van den Oord JJ, Desmet VJ. Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology 1990; 12: 59-65.
28. Yamashita Y, Tsuijita E, Takeishi K etal. Predictors for microinvasion of small hepatocellular carcinoma ≤ 2cm. Ann Surg Oncol 2012; 19: 2027-2034.